The Lens Pod podcast

The Lens Newsletter: July 2, 2025

2.7.2025
0:00
8:39
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Too busy to read the Lens? Listen to our weekly summary here! In this week's episode we discuss...

  • Certain systemic medications for T2DM may increase DME risk, while others are protective, suggesting medication choice impacts retinal health.

  • Daily low-dose valacyclovir reduces herpes zoster ophthalmicus-related recurrence at 18 months, supporting utility in long-term suppression.

  • RVO incidence rose during the COVID-19 pandemic in South Korea among middle-aged adults, while RAO rates remained stable. 

  • Nanopore sequencing shows promise for uveitis diagnosis, detecting herpes viruses with up to 75% sensitivity and 100% specificity.

Flere episoder fra "The Lens Pod"